How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut
Eli Lilly has a long, proud history that begins ... In 2009 the company’s then-CEO John Lechleiter and his leadership team ...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
In early 2018, Dave Ricks, the chief executive of the pharmaceutical giant Eli Lilly, was on a West ... His predecessor, John ...
pharmaphorum2d
Pharma gets social – LillyPad provides platform for Lilly's corporate engagement
Daniel Ghinn explores the processes behind launching LillyPad, global pharmaceutical company Eli Lilly’s corporate ... the case for change in Lilly. And CEO John Lechleiter was also already ...
pharmaphorum8y
Lilly soft tissue cancer drug gets EU nod
The news that Lartruvo will almost certainly be approved in the EU is a welcome piece of good news for Eli Lilly, at a time when the company waits for its new CEO to take charge. John Lechleiter ...